Director, Type2 Market Development

Tandem Diabetes Care
4d$160,000 - $189,000Remote

About The Position

The Director, T2 Market Development is responsible for developing, expanding, and operationalizing the external markets and channels required for Tandem’s Type 2 Diabetes (T2D) growth. This role leads commercial expansion efforts across Medicare (Part B and Part C), international markets (EU5, Canada, APAC, Middle East), and new care settings including Long-Term Care (LTC) and institutional environments. The Director shapes the payer value narrative, drives innovative access models such as ‘Pay as you go’ for Medicare Advantage plans, and creates novel commercial frameworks that enable the T2 ecosystem to scale across geographies and channels.

Requirements

  • Bachelor’s degree in business, economics, health policy, or related field, advanced degree (MBA, MHA, Ms of Health Economics, or similar) preferred or equivalent combination of education and experience.
  • 8+ years of experience in market development, commercial expansion, payer engagement, or global commercialization roles.
  • Experience working within diabetes, medical devices, or specialty therapeutics strongly preferred.
  • Prior experience with Medicare, MA plans, or OUS reimbursement pathways desirable.
  • Strong understanding of U.S. Medicare (Part B and Part C), pharmacy-benefit models, and diabetes reimbursement dynamics.
  • Experience with international commercial frameworks, including reimbursement and tender processes.
  • Excellent project management, communication, and negotiation abilities.
  • Ability to travel domestically and internationally as required (25-30%).

Responsibilities

  • Stands up and scales US growth pathways across priority segments and call points.
  • Reduces adoption friction (coverage workflow, documentation, affordability mechanics, patient journey handoffs) and improve conversion.
  • Partners with the Head of Govt Affairs to support and accelerate external efforts to eliminate the C-peptide requirement for Medicare Part B for pump therapy access.
  • Increases in US serviceable market (reachable HCP universe, channel capacity, covered/ practically-accessible lives).
  • Funnel performance: lead → trial → start → active; improved conversion at the biggest leakage points through the intake funnel, including patient training and onboarding to reduce time-to-start and administrative friction.
  • Builds and implements a Medicare Part C (Medicare Advantage) Pay as you go pharmacy benefit model for tubeless and MDI-replacement therapies.
  • Develops and executes international commercial expansion plans across priority markets (EU5, Canada, APAC), with tubeless-first market entry strategies.
  • Evaluates and develops new channel models for institutional care workflows.
  • Collaborates with Sales Enablement to ensure payer and channel changes translate into field-ready tools, messaging, and pull-through plans.
  • Conducts ongoing external landscape reviews of Medicare trends, global reimbursement shifts, competitive coverage changes, and institutional therapy patterns.

Benefits

  • Tandem offers health care benefits such as medical, dental, vision available your first day, as well as health savings accounts and flexible saving accounts.
  • You’ll also receive 11 paid holidays per year, unlimited PTO and you will have access to a 401k plan with company match as well as an Employee Stock Purchase plan.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service